Emotional Disorder Clinical Trial
— PsicAP-AOfficial title:
Transdiagnostic Group Cognitive Behavioral Therapy Versus Group Relaxation Therapy for Adolescents With Emotional Disorders (PsicAP-A): Protocol
NCT number | NCT04289740 |
Other study ID # | PsicAP-A |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 1, 2022 |
Est. completion date | April 1, 2023 |
Verified date | March 2022 |
Source | Instituto de Investigación Marqués de Valdecilla |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Emotional disorders such as anxiety and depression are highly prevalent during adolescence and associated with functional impairment that commonly extends into adulthood. In the primary care (PC) setting, these disorders are frequently underdiagnosed and undertreated. Objective: To carry out a prospective, randomized controlled trial (RCT) to test the efficacy of a new transdiagnostic cognitive behavioural group therapy (TD-CBT) protocol for adolescents (age 12 to 18 years) compared to group relaxation therapy (RT). Methods: Two-arm, single-blind, RCT (expected N=160) to compare group TD-CBT for emotional disorders to group RT. The group TD-CBT will be administered in seven sessions (90 min/session) over 12 weeks. Psychological assessments will be carried out at baseline, post-treatment, and at months 3, 6, and 12 after treatment. The assessments will include measures of depression, anxiety, somatization, quality of life, disability, and cognitive-emotional factors. The study will be conducted in two PC centres located in Cantabria, Spain. Discussion: This is the first RCT to evaluate the efficacy of group TD-CBT for emotional disorders in adolescents in the PC setting in Spain. If, as expected, the results confirm the superiority of TD-CBT to conventional RT, the widespread implementation of this new approach-based on scientific evidence obtained in a real-world, primary care setting-could improve treatment outcomes and quality of life in adolescents suffering from anxiety or depression.
Status | Recruiting |
Enrollment | 160 |
Est. completion date | April 1, 2023 |
Est. primary completion date | April 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Years to 18 Years |
Eligibility | Inclusion Criteria: - Patients aged 12 to 17, inclusive, who present to the PC centre seeking treatment for symptoms of anxiety or depression. - Scores above the predetermined cut-off points on the GAD-7 (>= 5) and PHQ-9 (>= 5). - Agreement to participate in the study, with written informed consent provided by both patients and parents/guardians. Exclusion Criteria: - Presence of any severe mental disorder, including autism spectrum disorders, bipolar disorder, schizophrenia, anorexia nervosa, substance dependence, personality disorder, and major depressive disorder (PHQ-9> 20). - Presence of severe or recent suicide attempts - Moderate or severe behaviour disorder that could interfere with the dynamics of the therapy groups. - Presence of a mental disability (IQ < 75). - Be receiving psychological treatment or any type of specialized care related to mental health. - Receiving any psychopharmacological treatment. - Parents involved in legal litigation due to separation or divorce. |
Country | Name | City | State |
---|---|---|---|
Spain | centro salud mental Girones | Girona | |
Spain | Centro Salud Mental Selva Marítima | Girona | |
Spain | Hospital de Laredo | Laredo | |
Spain | Hospital Sierrallana | Torrelavega |
Lead Sponsor | Collaborator |
---|---|
Instituto de Investigación Marqués de Valdecilla | Hospital de laredo, Hospital Sierrallana |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Depressive symptoms | Patient Health Questionnaire - 9 item (PHQ-9), adolescent version. Nine items assessing depressive symptoms with Likert response with values ranging from 0 to 3 (Total score range: 0-27; higher scores means a worse outcome) | 12 month follow-up period. | |
Primary | Depressive symptoms | Children's Depression Inventory, short version (CDI-S). Consists of 10 items answered on a three-point scale, where 0 = absence of the symptom, 1 = moderate symptom, and 2 = severe symptom. The total score ranges from 0 to 20. Higher scores means a worse outcome | 12 month follow-up period. | |
Primary | Anxiety symptoms | Generalized Anxiety Disorder - 7 item (GAD-7). It is composed of 7 Likert response items, ranging from 0 to 3 points (Total score range: 0-21). Higher scores means a worse outcome. | 12 month follow-up period. | |
Primary | Anxiety symptoms | Spence Children Anxiety Scale, short version (SCAS-S). It consists of 19 items, ranging from 0 to 3, as follows: 0 = "never", 1 = "sometimes", 2 = "many times", 3 =" always". Total scores range from 0-57 points. Higher scores means a worse outcome. | 12 month follow-up period. | |
Secondary | the Quality of life | KIDSCREEN-10 index. It is composed of 10 Likert response items, ranging from 1 to 5 points. (Total score range: 10-50). Higher scores means a better outcome. | 12 month follow-up period. | |
Secondary | Somatizations | PHQ-15. is composed of 15 Likert response items, ranging from 0 to 2 points. (Total score range: 0-30). Higher scores means a worse outcome. | 12 month follow-up period. | |
Secondary | Rumination | Ruminative Responses Scales (RRS), brooding subscale. It is composed of 5 Likert response items, ranging from 1 to 4 points. (Total score range: 5-20). Higher scores means a worse outcome. | 12 month follow-up period. | |
Secondary | Pathological worry | Penn State Worry Questionnaire (PSWQ), reduced 8-item version. It is composed of 8 Likert response items, ranging from 1 to 5 points. (Total score range: 5-40). Higher scores means a worse outcome. | 12 month follow-up period. | |
Secondary | Attentional and interpretative biases | Inventory of Cognitive Activity in Anxiety Disorders (IACTA), abbreviated 5-item version. It is composed of 5 Likert response items, ranging from 0 to 4 points. (Total score range: 0-20). Higher scores means a worse outcome. | 12 month follow-up period. | |
Secondary | Emotional regulation | Emotion Regulation Questionnaire (ERQ). It is composed of 10 Likert response items, ranging from 1 to 7 points. It assess two emotion-regulation strategies: cognitive reappraisal (6 items; range 6-42; higher scores means a better outcome) and expressive suppression (4 items; range 4-28: higher scores means a worse outcome) | 12 month follow-up period. | |
Secondary | Metacognitive beliefs | Metacognitions Questionnaire (MCQ-30); the 6-item negative metacognitive beliefs subscale.
It is composed of 6 Likert response items, ranging from 1 to 4 points. (Total score range: 6-24). Higher scores means a worse outcome. |
12 month follow-up period. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Active, not recruiting |
NCT04935593 -
Strengthening Social, Emotional and Behavioral Resilience
|
N/A | |
Not yet recruiting |
NCT05225701 -
Efficacy of a Transdiagnostic Guided Internet-Delivered Intervention for Emotional, Trauma and Stress-Related Disorders.
|
N/A | |
Recruiting |
NCT05172427 -
Acceptability/Feasibility of IU Intervention
|
N/A | |
Recruiting |
NCT03064477 -
The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System
|
N/A | |
Recruiting |
NCT05019053 -
Acceptability/Feasibility of COVID-19 Intervention
|
N/A | |
Active, not recruiting |
NCT04847310 -
Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care
|
N/A | |
Completed |
NCT04091633 -
School Health Implementation Network: Eastern Mediterranean
|
N/A | |
Not yet recruiting |
NCT06056232 -
Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation
|
N/A | |
Recruiting |
NCT06105567 -
The Effect of Education Given According to the Health Promotion Model on Premenstrual Symptoms, Emotional Eating Behavior and Perceived Stress
|
N/A | |
Recruiting |
NCT06373484 -
Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents
|
N/A | |
Completed |
NCT05589090 -
Super Skills for Life Effectiveness in the Online Modality
|
N/A | |
Completed |
NCT03312673 -
Asthma, Smoking, Emotional Deficits
|
||
Completed |
NCT03315208 -
Study of a Transdiagnostic, Emotion-focused Group Intervention for Young Adults With Substance Use Disorders
|
N/A | |
Completed |
NCT04182061 -
Internet Transdiagnostic-CBT for Anxiety and Depression in Adolescents
|
N/A | |
Not yet recruiting |
NCT05081830 -
Online Transdiagnostic Intervention for Emotional Disorders and Stress-related Disorders
|
N/A | |
Completed |
NCT04137471 -
Validation of the Ontological Addiction Scale
|
||
Completed |
NCT05482724 -
Super Skills for Life Effectiveness in Clinical Settings
|
N/A | |
Terminated |
NCT03904784 -
School Withdrawal in Adolescents
|
||
Recruiting |
NCT06361667 -
Culture and Well-being: Art as Prescription Therapy ("Art on Prescription")
|
N/A |